Read More Pharma Industry News Why Imugene is using a virus to “mark” tumors for CAR-T attack—and what JW Therapeutics brings to the table Find out how Imugene and JW Therapeutics plan to make solid tumors respond to CD19 CAR-T therapy using an oncolytic virus strategy. byVenkateshNovember 28, 2025